Engineered Bacteria and Viruses: A Cancer Breakthrough

Kilder

• Nature: Engineered bacteria launch and control an oncolytic virus - Nature
• Nature: Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial - Nature
• Bioworld: Precigen’s gene therapy for rare disease gets quick FDA approval - BioWorld MedTech
• Biospace: Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis - BioSpace
• Biospace: Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide - BioSpace
• Nature: Designing lipid nanoparticles using a transformer-based neural network - Nature

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.